title: Current strategies for management of hypertensive renal disease.
abstract: The incidence of hypertensive end-stage renal disease continues to increase annually. To reduce this incidence, it is necessary to control systolic and diastolic hypertension. Reversible causes should always be sought in any hypertensive patient who develops renal insufficiency. Blood pressure should be reduced to 130/85 mm Hg, and in African Americans with hypertensive renal failure, reducing the blood pressure to 120/75 mm Hg may be beneficial. Any antihypertensive treatment regimen that effectively lowers blood pressure will help slow progressive renal failure. Whenever possible, an angiotensin-converting enzyme inhibitor should be part of the treatment, since these drugs have been shown to be renoprotective beyond their antihypertensive effect in certain renal disease categories.
authors.affiliation: Danville Urologic Clinic, Va 24543-1360, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Moore
authors.forename: M
authors.initials: M
authors.lastname: Epstein
authors.forename: L
authors.initials: L
authors.lastname: Agodoa
authors.forename: L D
authors.initials: LD
authors.lastname: Dworkin
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D006801:Humans; D006977:Hypertension, Renal / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000959:Antihypertensive Agents